Clinical Trial Update: Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study of Linifanib in patients with advanced or refractory colorectal cancer was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Linifanib (linifanib)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-08-26